GLA 130 Primrose Oil

Name: GLA 130 Primrose Oil
Brand: Genestra Brands

BrandGenestra Brands→Fat/Fatty Acid Softgel Capsule 10 ingredients DSLD #230801

Net contents: 90 Softgel Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2020-07-23

2 Ingredients (10)

IngredientGroupSafety

CaloriesCalories—

Total FatFat (unspecified)—

Polyunsaturated FatPolyunsaturated Fat—

Evening Primrose (Oenothera biennis) seed Oilevening primrose oilConditionally Safe

Gamma-Linolenic AcidGamma Linolenic Acid—

Linoleic AcidLinoleic Acid—

Oleic AcidOleic Acid—

Palmitic AcidPalmitic Acid—

Capsulecapsule—

D-Alpha-TocopherolVitamin EConditionally Safe

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

3 Safety cross-reference

evening primrose oil — Conditionally Safe

⚠ May lower seizure threshold

⚠ Increased bleeding risk

Vitamin E — Conditionally Safe

⚠ Increased bleeding risk

⚠ All-cause mortality at >400 IU/day

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID230801

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2020-07-23

6 More from Genestra Brands

View Genestra Brands Safety Scorecard → 68 products

5HTP 100 mg Adreno Restore Amino L-Glutamine Amino L-Glutamine Powder Amino L-Lysine Amino L-Tyrosine

7 Cite this page

Vancouver

Pkhakadze G. GLA 130 Primrose Oil — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 20]. Available from: https://supplement.ge/products/gla-130-primrose-oil-230801/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG